$CODX Q4 '24 Earnings Results & Recap
Co-Diagnostics reported Q4 EPS of -$0.36 (vs. an estimated -$0.34) revenue of $0.15 million (vs. an estimated $0.38 million), with the company citing progress in its test pipeline and manufacturing capacity as positive developments, although setbacks in FDA approval timelines remain.